Javier Cortes, Joyce O’Shaughnessy u. a.: Eribulin monotherapy versus treatment of physician’s choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study. In: The Lancet, 377, 2011, S. 914, doi:10.1016/S0140-6736(11)60070-6.